This patent covers ways of purging tumor cells from bone marrow stem cell grafts. Specifically, the patent teachs ways of selectively protecting the bone marrow through gene transfection, while allowing tumor cells to die. This patent is particularly suited for situations of autolous bone marrow transplants in cancer patients in order to allow for high levels of chemotherapy and/or...
This patent teaches how to transfect male germ stem cells in non-human mammals. This technology is useful for generation of a variety of animal models for laboratory experimentation. It is also useful for research companies who want to circumvent some of the transgenic patents today.
This patent teaches how to utilize distinct electromagnetic properties of stem cells for their isolation. Additionally it teaches how to purge a population of stem cells from contaminating cancer cells.
It is known that hedgehog proteins are important in specifying what cells give rise to what tissues during development. Others have patented using hedgehog proteins for stimulating insulin production. In this patent the inventors found a new use for hedgehog proteins besides their known role in embryogenesis. Initially, the...
This patent teaches how to determine the number of stem cells in a tissue culture situation through assessing various metabolic properties of the tissue culture media.
Usually bone marrow is extracted from the iliac crest of patients. In this patent a new device for extracting bone marrow is disclosed. The patent is useful for, intra alia, taking out bone marrow from the jaw bone of a subject that is undergoing dental surgery. If you thought root canals are painful, imagine this !
This patent provides procedures and devices useful for harvesting bone marrow. In one embodiment the bone marrow is harvested from the jaw of the patient.
This patent teaches methods and discloses devices, that are useful for the extraction of bone marrow stem cells from the jawbone of a patient.
This patent is directed to the stimulation of hematopoietic stem cell proliferation by use of a lectin called FRIL. The patent has 2 independent claims. The first is directed towards a pharmaceutical composition claiming some distinct sequences that bind glycosylated flt-3. The second is directed towards treatment, using the same sequences. There is a paper...
This patent teaches that certain lectins (sugar binding proteins) may be used for the preservation of progenitor cells and stem cells. It is not clear which property of the lectins is involved in the preservation. The concept that lectins may be used in stem cell preservation brings to mind old experiments in which the preferentially affinity of lectins to cancer cell membranes was...